Corpus ID: 29917713

[Immunotherapy for type 1 diabetes mellitus (DM1)].

@article{Torren2012ImmunotherapyFT,
  title={[Immunotherapy for type 1 diabetes mellitus (DM1)].},
  author={C. R. van der Torren and B. Roep},
  journal={Nederlands tijdschrift voor geneeskunde},
  year={2012},
  volume={156 15},
  pages={
          A4268
        }
}
Treatment of type 1 diabetes mellitus (DM1) has greatly improved but remains limited to combating the consequences of the disease. Target values for glucose regulation are achieved in only 20% of patients. Immunosuppression can slow disease progression, but does not cure DM1. Immunotherapy attempts to protect remaining insulin-producing β cells and β cell function. Promising results of immunotherapy in phase 2 studies in patients with DM1 could not be reproduced in phase 3 studies. These… Expand
1 Citations